Univar Solutions has reached an agreement with W. R. Grace (Grace) to distribute Grace's SYLOID FP silica for pharmaceutical and nutraceutical markets in the majority of European countries.
The agreement builds upon the existing global relationship between Univar Solutions and Grace in the United States, Brazil, Mexico, and the majority of Europe providing customers access to this multifunctional excipient used in over the counter and prescription drug delivery solutions and supplements.
"Excipients are emerging as strategic drug enhancement tools in the growing pharmaceutical and nutraceutical markets. We are extremely pleased to further extend our longtime partnership with Grace, a leading excipient manufacturer," said James Peterson, Global Vice President of Pharmaceutical Ingredients for Univar Solutions.
"Grace and its customers in major European markets will benefit from our dedicated sales and product management teams, application-specific technical support, and complementary product portfolio. We look forward to helping expedite any qualification processes with our global regulatory resources, product samples, and technical application expertise."
Excipients are emerging as strategic drug enhancement tools in the growing pharmaceutical and nutraceutical markets
Grace SYLOID FP silica contributes efficiency and performance in many pharmaceutical and nutraceutical applications, helping to address powder flow and caking challenges. SYLOID FP silica is engineered hydrated silicon dioxide produced under controlled conditions, meeting USP/NF, EMA, JP, and ANVISA requirements and offering high chemical purity and performance.
SYLOID FP silica is easy to incorporate, offering optimal performance as a glidant, carrier for active ingredients, tableting aid, thickener and disintegrant, which helps improve the handling, adsorption, and dissolution of many pharmaceuticals and nutraceuticals.
The excipient's unique design combines adsorption capacity, particle size, density, and internal surface area to provide multifunctional benefits or optimise an application. This helps minimise the number of excipients used and the complexity of formulations while expediting manufacturing, ultimately improving the efficacy of the final dosage form.
"Univar Solutions is a world-class organisation with an excellent track record in delivering high-value specialty products and services to pharmaceutical and nutraceutical markets. Grace is proud to partner with Univar Solutions and support their portfolio expansion with the addition of SYLOID FP silica, a leading multi-functional excipient trusted by global organisations for over 50 years," said John Gilbert, VP of sales for Grace Materials Technologies.
